PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 2,895.00
+45.00 (1.58%)
Last updated: Oct 6, 2026, 3:00 PM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 65.46 billion as of October 6, 2026. Its market cap has decreased by -20.47% in one year.
Market Cap
65.46B
Enterprise Value
70.81B
Revenue
171.66B
Ranking
n/a
PE Ratio
555.95
Stock Price
2,895.00
ChartMarket Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 65.46B, an increase of 501.02%. That is a compound annual growth rate of 5.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 65.46B | -28.10% |
| Dec 30, 2025 | 91.05B | 22.74% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 59.05T |
| Celltrion | 41.92T |
| ALTEOGEN | 17.90T |
| Samsung Epis Holdings | 9.16T |
| Humasis | 70.57B |
| Amicogen | 70.45B |
| CG Invites | 69.90B |
| P&S Robotics | 69.56B |